The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world impact of hepatocellular carcinoma stage and hepatic function on health-related quality of life.
 
Amol Gupta
No Relationships to Disclose
 
Jane Zorzi
No Relationships to Disclose
 
Won Jin Ho
Honoraria - Exelixis; Standard BioTools
Research Funding - NeoTX; Sanofi
Patents, Royalties, Other Intellectual Property - Amgen; Rodeo Therapeutics
Travel, Accommodations, Expenses - Exelixis; Standard BioTools
 
Marina Baretti
No Relationships to Disclose
 
Nilofer Saba Azad
Stock and Other Ownership Interests - Haystack Oncology
Consulting or Advisory Role - AstraZeneca; Helsinn Therapeutics/QED Therapeutics; Incyte; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Merck; Mirati Therapeutics; QED Therapeutics; Taiho Pharmaceutical
Speakers' Bureau - AstraZeneca
Research Funding - Agios (Inst); Array BioPharma (Inst); Astex Pharmaceuticals (Inst); AtlasMedx (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); EMD Serono (Inst); Genentech (Inst); Incyte (Inst); Intensity Therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Paige Griffith
Consulting or Advisory Role - Eisai/H3 Biomedicine; Exelixis
Travel, Accommodations, Expenses - Helsinn Therapeutics
 
Doan Dao
No Relationships to Disclose
 
Amy K. Kim
No Relationships to Disclose
 
Benjamin Philosophe
No Relationships to Disclose
 
Christos Georgiades
No Relationships to Disclose
 
Ihab R. Kamel
Research Funding - Siemens Healthineers
 
Richard Burkhart
No Relationships to Disclose
 
Robert Liddell
No Relationships to Disclose
 
Kelvin Hong
Consulting or Advisory Role - Boston Scientific; BTG
Research Funding - BTG
 
Christopher Shubert
Honoraria - Fujifilm
Consulting or Advisory Role - Exelixis
 
Kelly Lafaro
No Relationships to Disclose
 
Jeffrey Meyer
Honoraria - Springer; UpToDate
Research Funding - Boston Scientific
 
Robert A. Anders
Employment - Johns Hopkins Hospital
Honoraria - Peerview
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bristol-Myers Squibb/Medarex; Merck
Research Funding - Bristol-Myers Squibb/Medarex; RAPT Therapeutics; Stand up to Cancer
 
William Burns
No Relationships to Disclose
 
Mark Yarchoan
Leadership - Adventris Pharmaceuticals
Stock and Other Ownership Interests - Adventris Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Genentech/Roche; Hepion Pharmaceuticals; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Incyte (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Merck